'Strain change' diaporamas de présentation

Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review FDA/CBER 23 July 2009

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE FDA Regulatory Pathway To Facilitate the Licensure and Availability of Pandemic (H1N1) 2009 Influenza Virus Vaccines. Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review FDA/CBER 23 July 2009. Introduction.

290 views • 12 slides

Influenza Virus Vaccine 2007-2008 Strain Selection

Influenza Virus Vaccine 2007-2008 Strain Selection. Rakesh Pandey, Ph.D. Division of Vaccines and Related Products Applications FDA/CBER/OVRR Vaccines and Related Biological Products Advisory Committee, 28 February 2007. VRBPAC Committee Recommendation.

235 views • 11 slides

Licensure of Pandemic Influenza Vaccines: Demonstration of Effectiveness

347 views • 10 slides

Physics Notes Ch 9

223 views • 10 slides

Influenza Vaccine Manufacturing

Influenza Vaccine Manufacturing. Industry Perspective for 2009-2010 Vaccine Supply . 2008-2009 Inactivated Influenza Vaccine . Potentially significant supply shortage averted even with 3 strain change due to

250 views • 7 slides